Go Pro
NASDAQ:VMD

Viemed Healthcare (VMD) Stock Price, News & Analysis

Viemed Healthcare logo
$9.73 +0.21 (+2.21%)
Closing price 08/7/2026 04:00 PM Eastern
Extended Trading
$9.72 -0.01 (-0.05%)
As of 08/7/2026 07:34 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

About Viemed Healthcare Stock (NASDAQ:VMD)

Advanced

Key Stats

Today's Range
$9.51
$9.80
50-Day Range
$9.48
$12.33
52-Week Range
$6.05
$12.61
Volume
405,977 shs
Average Volume
375,785 shs
Market Capitalization
$370.62 million
P/E Ratio
27.03
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
Hold

Company Overview

Viemed Healthcare, Inc. (NASDAQ: VMD) is a provider of home-based respiratory therapy services, specializing in the management of patients requiring long-term mechanical ventilation and pulmonary support. The company’s offerings encompass invasive and noninvasive ventilation, airway clearance therapies, cough assist devices, and supplemental oxygen. Viemed combines durable medical equipment with clinical care, delivering tailored respiratory treatment plans that are overseen by licensed respiratory therapists and registered nurses.

Founded in the early 2010s and headquartered in Birmingham, Alabama, Viemed has grown its footprint to serve patients across multiple states in the United States. The company partners with hospitals, skilled nursing facilities, and physician practices to facilitate smooth transitions from acute care to the home setting. Viemed’s model emphasizes early intervention, patient education, and close monitoring to reduce hospital readmissions and improve quality of life for individuals with chronic respiratory conditions such as COPD, neuromuscular diseases, and spinal cord injuries.

In addition to equipment delivery, Viemed provides telemonitoring and home health services, enabling continuous remote oversight of patient ventilation parameters and clinical status. Its clinical team works collaboratively with referring physicians to adjust care plans in real time and to address emerging respiratory needs. Through these integrated services, Viemed aims to enhance patient outcomes, lower overall healthcare costs, and set a standard for home respiratory care across its service regions.

AI Generated. May Contain Errors.

Viemed Healthcare Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
56th Percentile Overall Score

VMD MarketRank™: 

Viemed Healthcare scored higher than 56% of companies evaluated by MarketBeat, and ranked 423rd out of 905 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Viemed Healthcare has received a consensus rating of Hold. The company's average rating score is 2.33, and is based on no strong buy ratings, 1 buy rating, 2 hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    Viemed Healthcare has only been the subject of 2 research reports in the past 90 days.

  • Read more about Viemed Healthcare's stock forecast and price target.
  • Earnings Growth

    Earnings for Viemed Healthcare are expected to grow by 31.82% in the coming year, from $0.44 to $0.58 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Viemed Healthcare is 27.03, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 39.61.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Viemed Healthcare is 27.03, which means that it is trading at a less expensive P/E ratio than the Healthcare sector average P/E ratio of about 271.39.

  • Price to Book Value per Share Ratio

    Viemed Healthcare has a P/B Ratio of 2.54. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

  • Percentage of Shares Shorted

    2.45% of the float of Viemed Healthcare has been sold short.
  • Short Interest Ratio / Days to Cover

    Viemed Healthcare has a short interest ratio ("days to cover") of 2.38, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Viemed Healthcare has recently increased by 43.92%, indicating that investor sentiment is decreasing significantly.
  • Dividend Yield

    Viemed Healthcare does not currently pay a dividend.

  • Dividend Growth

    Viemed Healthcare does not have a long track record of dividend growth.

  • News Sentiment

    Viemed Healthcare has a news sentiment score of 0.05. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.54 average news sentiment score of Healthcare companies.
  • News Coverage This Week

    MarketBeat has tracked 9 news articles for Viemed Healthcare this week, compared to 1 article on an average week.
  • MarketBeat Follows

    3 people have added Viemed Healthcare to their MarketBeat watchlist in the last 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Viemed Healthcare insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $347,200.00 in company stock.

  • Percentage Held by Insiders

    20.60% of the stock of Viemed Healthcare is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    74.24% of the stock of Viemed Healthcare is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Viemed Healthcare's insider trading history.
Receive VMD Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Viemed Healthcare and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

VMD Stock News Headlines

SpaceX Earnings Crash: The End of the AI Bubble?
Jeremy Grantham calls today's market the biggest investment bubble in American history, and Ray Dalio agrees. SpaceX's latest earnings disappointed, and Morgan Stanley and Goldman Sachs now warn of a much bigger crisis unfolding over the next decade. TradeSmith CEO Keith Kaplan says there's another side to the AI story most people aren't discussing.tc pixel
See More Headlines

VMD Stock Analysis - Frequently Asked Questions

Viemed Healthcare's stock was trading at $7.43 at the beginning of the year. Since then, VMD stock has increased by 31.0% and is now trading at $9.73.

Viemed Healthcare, Inc. (NASDAQ:VMD) posted its earnings results on Monday, August, 3rd. The company reported $0.07 EPS for the quarter, missing analysts' consensus estimates of $0.12 by $0.05. The firm earned $78.10 million during the quarter, compared to the consensus estimate of $78 million. Viemed Healthcare had a net margin of 4.81% and a trailing twelve-month return on equity of 10.16%.
Read the conference call transcript
.

Viemed Healthcare's top institutional shareholders include BlackRock Inc. (12.57%), Rice Hall James & Associates LLC (0.55%), GSA Capital Partners LLP (0.33%) and Bank of New York Mellon Corp (0.24%). Insiders that own company stock include Michael Moore, Nitin Kaushal, Randy E Dobbs, Jerome Cambre, Timothy Smokoff, William Frazier and Sabrina Heltz.
View institutional ownership trends
.

Shares of VMD stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Viemed Healthcare investors own include Myomo (MYO), Alpha Teknova (TKNO), Heron Therapeutics (HRTX), Advanced Micro Devices (AMD), Zevra Therapeutics (ZVRA) and Enterprise Products Partners (EPD).

Company Calendar

Last Earnings
8/03/2026
Today
8/08/2026
Fiscal Year End
12/31/2026

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Industry
Healthcare Providers & Services
Sub-Industry
Healthcare Services
Current Symbol
NASDAQ:VMD
CIK
1729149
Fax
N/A
Employees
1,382
Year Founded
2006

Profitability

EPS (Trailing Twelve Months)
$0.36
Trailing P/E Ratio
27.03
Forward P/E Ratio
22.11
P/E Growth
N/A
Net Income
$14.93 million
Net Margins
4.81%
Pretax Margin
7.02%
Return on Equity
10.16%
Return on Assets
7.22%

Debt

Debt-to-Equity Ratio
0.04
Current Ratio
1.13
Quick Ratio
1.10

Sales & Book Value

Annual Sales
$270.28 million
Price / Sales
1.37
Cash Flow
$1.18 per share
Price / Cash Flow
8.27
Book Value
$3.83 per share
Price / Book
2.54

Miscellaneous

Outstanding Shares
38,090,000
Free Float
30,242,000
Market Cap
$370.62 million
Optionable
Not Optionable
Beta
1.10

Social Links

7 Stocks That Could Lead the Next Market Boom Cover

Tesla, Nvidia, and Google helped shape the last era of market growth, but the next wave could come from a new group of companies. Inside this report, you’ll find 7 stocks that could play a major role in the next tech-driven market boom.

Get This Free Report

This page (NASDAQ:VMD) was last updated on 8/8/2026 by MarketBeat.com Staff.
From Our Partners